Patent · US Active

Enhancement of placental stem cell potency using modulatory RNA molecules

US8969315B2 · kind B2 · utility

2Cited by

214References

8Claims

0Family size

Assignee

Anthrogenesis Corporation · US

Inventors

Stewart Abbot · Hackettstown, US
Kathy Karasiewicz-Mendez · Fryeburg, US
Vanessa Voskinarian-Berse · Millington, US
Xiaokui Zhang · Northborough, US

Key dates

Filing date	Dec 29, 2011
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Dec 29, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2501/65
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.